Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Evrysdi“
Suchtreffer
Begriffe & Kennungen
Evrysdi
Eintrag öffnenEvrysdi · 4.1 Therapeutic indications · 1
Eintrag öffnenEvrysdi · 4.1 Therapeutic indications · 2
Eintrag öffnenEvrysdi · 4.3 Contraindications · 1
Eintrag öffnenEvrysdi · 4.3 Contraindications · 2
Eintrag öffnenEvrysdi · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenEvrysdi · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenEvrysdi · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenEvrysdi · 4.4 Special warnings and precautions for use · 2
Eintrag öffnenEvrysdi · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenEvrysdi · 4.5 Interaction with other medicinal products and other forms of interaction · 2
Eintrag öffnenEvrysdi · 4.5 · 4 Effects of risdiplam on other medicinal products
Eintrag öffnenEvrysdi · 4.5 · Co‑administration of 200 mg itraconazole twice daily, a strong CYP3A inhibitor, with a single oral dose of 6 m
Eintrag öffnenEvrysdi · 4.5 · Co‑administration of 200 mg itraconazole twice daily, a strong CYP3A inhibitor, with a single oral dose of 6 m
Eintrag öffnenEvrysdi · 4.5 · Effects of other medicinal products on risdiplam
Eintrag öffnenEvrysdi · 4.5 · Effects of other medicinal products on risdiplam
Eintrag öffnenEvrysdi · 4.5 · Effects of risdiplam on other medicinal products
Eintrag öffnenEvrysdi · 4.5 · In vitro studies have shown that risdiplam and its major human metabolite M1 are not significant inhibitors of
Eintrag öffnenEvrysdi · 4.5 · In vitro studies have shown that risdiplam and its major human metabolite M1 are not significant inhibitors of
Eintrag öffnenEvrysdi · 4.5 · No drug‑drug interactions are expected via the FMO1 and FMO3 pathway.
Eintrag öffnen